Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality
| Autor: | Mona Saraiya, Albert K. Kwan, Crystale Purvis Cooper |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
medicine.medical_specialty Epidemiology medicine.medical_treatment MEDLINE Uterine Cervical Neoplasms Cervical cancer screening Logistic regression Article 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires Humans Mass Screening Medicine 030212 general & internal medicine Pap test Early Detection of Cancer Mass screening Aged Cervical cancer Internet Hysterectomy medicine.diagnostic_test business.industry Obstetrics Papillomavirus Infections Public Health Environmental and Occupational Health virus diseases Patient Preference Awareness Middle Aged medicine.disease United States female genital diseases and pregnancy complications Hpv testing 030220 oncology & carcinogenesis Female business |
| Zdroj: | Preventive Medicine. 108:111-114 |
| ISSN: | 0091-7435 |
| Popis: | Background Primary HPV testing (without the Pap test) has recently been recommended as a cervical cancer screening option in the United States. U.S. women's awareness and acceptance of primary HPV testing were evaluated. Methods Data from a 2015 web-based survey of U.S. adults was examined. Analyses were limited to women who were ≥ 18 years old, had not undergone a hysterectomy, had not been diagnosed with cervical cancer, and would accept cervical cancer screening (N = 1309). Logistic regression was used to identify predictors of acceptance of primary HPV testing every 3 years. Results Primary HPV testing every 3 years was the least accepted cervical cancer screening option (13.5%), and annual Pap testing was the most accepted (41.2%). Most women (65.2%) reported that they were unsure how the HPV test is administered. HPV-vaccinated women were more likely to accept primary HPV testing every 3 years than unvaccinated women (Adj OR = 1.80, 95% CI = 1.22–2.63, p = 0.003). And, women who had participated in HPV testing at any interval were more likely to accept primary HPV testing every 3 years than those who did not have regular HPV tests or were unsure how often they had HPV tests (Adj OR = 1.74, 95% CI = 1.20–2.52, p = 0.003). Conclusions Acceptance of primary HPV testing among U.S. women was low and associated with variables which may be indicative of general HPV awareness. Widespread adoption of primary HPV testing may require increasing women's familiarity with the HPV test and screening guidelines. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect